Reimbursement Insight Services
These timely, insight-driven subscription research services provide year-round updates about what your most important customers are thinking
Each year, Reimbursement Intelligence parallel surveys of payers and providers draw out their views and evolving thinking about latest therapeutic developments in multiple key markets. Surveys are timed to coincide with the release of new clinical data at the annual congresses of key specialty organizations including:
- Oncology/Hematology
- Rheumatology
- Neurology
- Infectious Disease
The RI Reimbursement Insight surveys focus on issues that are central to understanding the impact of current and emerging reimbursement and access trends in some of today’s most challenging markets. By subscribing to the RI Reimbursement Insight service, you can be better prepared to answer key strategic questions that directly impact the success of your brand:
- How and where are payers actually restricting access – and how can I play to win?
- What is it going to take to win preferred status—and can I afford it? Are there more profitable and achievable goals?
- What are the implications of the current landscape for my pipeline products, and what does it mean for the ways we’re designing our studies?
- How will the landscape evolve with introduction of new generic formulations, including biosimilars?
- Are my current strategies on target from payers’ perspectives?
- What initiatives – such as CER, rebates, or cost-offsetting programs for patients – should I be investing in?
- How does the perceived value of my offerings to payers, providers and patients stack up against those of my competitors?